APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dutasteride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025196 pages

Choose your research edition.

Industry ResearchDutasteride Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Dutasteride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Drug Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Dutasteride Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dutasteride Drug include GSK, Acella Pharmaceuticals, Amneal Pharmaceuticals, Ascent Pharmaceuticals, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Endo and Strides Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dutasteride Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dutasteride Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dutasteride Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dutasteride Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Dutasteride Drug Segment by Company

GSK

Acella Pharmaceuticals

Amneal Pharmaceuticals

Ascent Pharmaceuticals

Aurobindo Pharma

Barr Pharmaceuticals

Chartwell

Endo

Strides Pharma

Waylis Therapeutics

Zydus

Chengdu Suncadia Medicine

Jiangsu Wangao Pharmaceutical

Qilu Pharmaceutical

Humanwell Puracap

Sichuan Gowell Pharmaceutical

Dutasteride Drug Segment by Type

Single Drug

Combination Preparation

Dutasteride Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Dutasteride Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dutasteride Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dutasteride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dutasteride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dutasteride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dutasteride Drug Industry Trends Table 2. Dutasteride Drug Industry Drivers Table 3. Dutasteride Drug Industry Opportunities and Challenges Table 4. Dutasteride Drug Industry Restraints Table 5. Global Dutasteride Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dutasteride Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dutasteride Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dutasteride Drug Sales Market Share by Manufacturers Table 9. Global Dutasteride Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dutasteride Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dutasteride Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dutasteride Drug Manufacturers, Product Type & Application Table 13. Global Dutasteride Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dutasteride Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Drug Table 17. Major Manufacturers of Combination Preparation Table 18. Global Dutasteride Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 20. Global Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 21. Global Dutasteride Drug Sales Market Share by Type (2021-2026) Table 22. Global Dutasteride Drug Sales Market Share by Type (2027-2032) Table 23. Global Dutasteride Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Dutasteride Drug Revenue by Type (2021-2026) & (K Units) Table 25. Global Dutasteride Drug Revenue by Type (2027-2032) & (K Units) Table 26. Global Dutasteride Drug Revenue Market Share by Type (2021-2026) Table 27. Global Dutasteride Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacy Table 29. Major Manufacturers of Hospital Pharmacy Table 30. Major Manufacturers of Online Pharmacy Table 31. Global Dutasteride Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 33. Global Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 34. Global Dutasteride Drug Sales Market Share by Application (2021-2026) Table 35. Global Dutasteride Drug Sales Market Share by Application (2027-2032) Table 36. Global Dutasteride Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Dutasteride Drug Revenue by Application (2021-2026) & (K Units) Table 38. Global Dutasteride Drug Revenue by Application (2027-2032) & (K Units) Table 39. Global Dutasteride Drug Revenue Market Share by Application (2021-2026) Table 40. Global Dutasteride Drug Revenue Market Share by Application (2027-2032) Table 41. Global Dutasteride Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Dutasteride Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Dutasteride Drug Sales Market Share by Region (2021-2026) Table 44. Global Dutasteride Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Dutasteride Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 48. North America Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 49. Europe Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 51. Europe Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 58. Global Dutasteride Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dutasteride Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dutasteride Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dutasteride Drug Revenue Market Share by Region (2021-2026) Table 62. Global Dutasteride Drug Revenue Market Share by Region (2027-2032) Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GSK Dutasteride Drug Product Portfolio Table 67. GSK Recent Development Table 68. Acella Pharmaceuticals Company Information Table 69. Acella Pharmaceuticals Business Overview Table 70. Acella Pharmaceuticals Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Acella Pharmaceuticals Dutasteride Drug Product Portfolio Table 72. Acella Pharmaceuticals Recent Development Table 73. Amneal Pharmaceuticals Company Information Table 74. Amneal Pharmaceuticals Business Overview Table 75. Amneal Pharmaceuticals Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Amneal Pharmaceuticals Dutasteride Drug Product Portfolio Table 77. Amneal Pharmaceuticals Recent Development Table 78. Ascent Pharmaceuticals Company Information Table 79. Ascent Pharmaceuticals Business Overview Table 80. Ascent Pharmaceuticals Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ascent Pharmaceuticals Dutasteride Drug Product Portfolio Table 82. Ascent Pharmaceuticals Recent Development Table 83. Aurobindo Pharma Company Information Table 84. Aurobindo Pharma Business Overview Table 85. Aurobindo Pharma Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Aurobindo Pharma Dutasteride Drug Product Portfolio Table 87. Aurobindo Pharma Recent Development Table 88. Barr Pharmaceuticals Company Information Table 89. Barr Pharmaceuticals Business Overview Table 90. Barr Pharmaceuticals Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Barr Pharmaceuticals Dutasteride Drug Product Portfolio Table 92. Barr Pharmaceuticals Recent Development Table 93. Chartwell Company Information Table 94. Chartwell Business Overview Table 95. Chartwell Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Chartwell Dutasteride Drug Product Portfolio Table 97. Chartwell Recent Development Table 98. Endo Company Information Table 99. Endo Business Overview Table 100. Endo Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Endo Dutasteride Drug Product Portfolio Table 102. Endo Recent Development Table 103. Strides Pharma Company Information Table 104. Strides Pharma Business Overview Table 105. Strides Pharma Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Strides Pharma Dutasteride Drug Product Portfolio Table 107. Strides Pharma Recent Development Table 108. Waylis Therapeutics Company Information Table 109. Waylis Therapeutics Business Overview Table 110. Waylis Therapeutics Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Waylis Therapeutics Dutasteride Drug Product Portfolio Table 112. Waylis Therapeutics Recent Development Table 113. Zydus Company Information Table 114. Zydus Business Overview Table 115. Zydus Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Zydus Dutasteride Drug Product Portfolio Table 117. Zydus Recent Development Table 118. Chengdu Suncadia Medicine Company Information Table 119. Chengdu Suncadia Medicine Business Overview Table 120. Chengdu Suncadia Medicine Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio Table 122. Chengdu Suncadia Medicine Recent Development Table 123. Jiangsu Wangao Pharmaceutical Company Information Table 124. Jiangsu Wangao Pharmaceutical Business Overview Table 125. Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio Table 127. Jiangsu Wangao Pharmaceutical Recent Development Table 128. Qilu Pharmaceutical Company Information Table 129. Qilu Pharmaceutical Business Overview Table 130. Qilu Pharmaceutical Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Qilu Pharmaceutical Dutasteride Drug Product Portfolio Table 132. Qilu Pharmaceutical Recent Development Table 133. Humanwell Puracap Company Information Table 134. Humanwell Puracap Business Overview Table 135. Humanwell Puracap Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Humanwell Puracap Dutasteride Drug Product Portfolio Table 137. Humanwell Puracap Recent Development Table 138. Sichuan Gowell Pharmaceutical Company Information Table 139. Sichuan Gowell Pharmaceutical Business Overview Table 140. Sichuan Gowell Pharmaceutical Dutasteride Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio Table 142. Sichuan Gowell Pharmaceutical Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Dutasteride Drug Distributors List Table 146. Dutasteride Drug Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Dutasteride Drug Product Image Figure 2. Global Dutasteride Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dutasteride Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Dutasteride Drug Sales (2021-2032) & (K Units) Figure 5. Global Dutasteride Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dutasteride Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Drug Image Figure 9. Combination Preparation Image Figure 10. Global Dutasteride Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Dutasteride Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dutasteride Drug Sales Market Share by Type (2021-2032) Figure 13. Global Dutasteride Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dutasteride Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dutasteride Drug Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacy Image Figure 17. Hospital Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Global Dutasteride Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Dutasteride Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dutasteride Drug Sales Market Share by Application (2021-2032) Figure 22. Global Dutasteride Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Dutasteride Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dutasteride Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 39. China Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Dutasteride Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Dutasteride Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dutasteride Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dutasteride Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dutasteride Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dutasteride Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dutasteride Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dutasteride Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dutasteride Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • GSK
  • Acella Pharmaceuticals
  • Amneal Pharmaceuticals
  • Ascent Pharmaceuticals
  • Aurobindo Pharma
  • Barr Pharmaceuticals
  • Chartwell
  • Endo
  • Strides Pharma
  • Waylis Therapeutics
  • Zydus
  • Chengdu Suncadia Medicine
  • Jiangsu Wangao Pharmaceutical
  • Qilu Pharmaceutical
  • Humanwell Puracap
  • Sichuan Gowell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dutasteride Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dutasteride Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dutasteride Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dutasteride Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dutasteride Drug Market Dynamics
  1. 2.1 Dutasteride Drug Industry Trends
  2. 2.2 Dutasteride Drug Industry Drivers
  3. 2.3 Dutasteride Drug Industry Opportunities and Challenges
  4. 2.4 Dutasteride Drug Industry Restraints
3 Dutasteride Drug Market by Manufacturers
  1. 3.1 Global Dutasteride Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dutasteride Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dutasteride Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dutasteride Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dutasteride Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dutasteride Drug Manufacturers, Product Type & Application
  7. 3.7 Global Dutasteride Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dutasteride Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dutasteride Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dutasteride Drug Tier 1, Tier 2, and Tier 3
4 Dutasteride Drug Market by Type
  1. 4.1 Dutasteride Drug Type Introduction
  2. 4.1.1 Single Drug
  3. 4.1.2 Combination Preparation
  4. 4.2 Global Dutasteride Drug Sales by Type
  5. 4.2.1 Global Dutasteride Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dutasteride Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Dutasteride Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dutasteride Drug Revenue by Type
  9. 4.3.1 Global Dutasteride Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dutasteride Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Dutasteride Drug Revenue Market Share by Type (2021-2032)
5 Dutasteride Drug Market by Application
  1. 5.1 Dutasteride Drug Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Dutasteride Drug Sales by Application
  6. 5.2.1 Global Dutasteride Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dutasteride Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Dutasteride Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dutasteride Drug Revenue by Application
  10. 5.3.1 Global Dutasteride Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dutasteride Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Dutasteride Drug Revenue Market Share by Application (2021-2032)
6 Global Dutasteride Drug Sales by Region
  1. 6.1 Global Dutasteride Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dutasteride Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Dutasteride Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Dutasteride Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dutasteride Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dutasteride Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dutasteride Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dutasteride Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dutasteride Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dutasteride Drug Revenue by Region
  1. 7.1 Global Dutasteride Drug Revenue by Region
  2. 7.1.1 Global Dutasteride Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dutasteride Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Dutasteride Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Dutasteride Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dutasteride Drug Revenue (2021-2032)
  8. 7.2.2 North America Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dutasteride Drug Revenue (2021-2032)
  11. 7.3.2 Europe Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dutasteride Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dutasteride Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dutasteride Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Dutasteride Drug Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Acella Pharmaceuticals
  8. 8.2.1 Acella Pharmaceuticals Company Information
  9. 8.2.2 Acella Pharmaceuticals Business Overview
  10. 8.2.3 Acella Pharmaceuticals Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Acella Pharmaceuticals Dutasteride Drug Product Portfolio
  12. 8.2.5 Acella Pharmaceuticals Recent Developments
  13. 8.3 Amneal Pharmaceuticals
  14. 8.3.1 Amneal Pharmaceuticals Company Information
  15. 8.3.2 Amneal Pharmaceuticals Business Overview
  16. 8.3.3 Amneal Pharmaceuticals Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amneal Pharmaceuticals Dutasteride Drug Product Portfolio
  18. 8.3.5 Amneal Pharmaceuticals Recent Developments
  19. 8.4 Ascent Pharmaceuticals
  20. 8.4.1 Ascent Pharmaceuticals Company Information
  21. 8.4.2 Ascent Pharmaceuticals Business Overview
  22. 8.4.3 Ascent Pharmaceuticals Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ascent Pharmaceuticals Dutasteride Drug Product Portfolio
  24. 8.4.5 Ascent Pharmaceuticals Recent Developments
  25. 8.5 Aurobindo Pharma
  26. 8.5.1 Aurobindo Pharma Company Information
  27. 8.5.2 Aurobindo Pharma Business Overview
  28. 8.5.3 Aurobindo Pharma Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aurobindo Pharma Dutasteride Drug Product Portfolio
  30. 8.5.5 Aurobindo Pharma Recent Developments
  31. 8.6 Barr Pharmaceuticals
  32. 8.6.1 Barr Pharmaceuticals Company Information
  33. 8.6.2 Barr Pharmaceuticals Business Overview
  34. 8.6.3 Barr Pharmaceuticals Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Barr Pharmaceuticals Dutasteride Drug Product Portfolio
  36. 8.6.5 Barr Pharmaceuticals Recent Developments
  37. 8.7 Chartwell
  38. 8.7.1 Chartwell Company Information
  39. 8.7.2 Chartwell Business Overview
  40. 8.7.3 Chartwell Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chartwell Dutasteride Drug Product Portfolio
  42. 8.7.5 Chartwell Recent Developments
  43. 8.8 Endo
  44. 8.8.1 Endo Company Information
  45. 8.8.2 Endo Business Overview
  46. 8.8.3 Endo Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Endo Dutasteride Drug Product Portfolio
  48. 8.8.5 Endo Recent Developments
  49. 8.9 Strides Pharma
  50. 8.9.1 Strides Pharma Company Information
  51. 8.9.2 Strides Pharma Business Overview
  52. 8.9.3 Strides Pharma Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Strides Pharma Dutasteride Drug Product Portfolio
  54. 8.9.5 Strides Pharma Recent Developments
  55. 8.10 Waylis Therapeutics
  56. 8.10.1 Waylis Therapeutics Company Information
  57. 8.10.2 Waylis Therapeutics Business Overview
  58. 8.10.3 Waylis Therapeutics Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Waylis Therapeutics Dutasteride Drug Product Portfolio
  60. 8.10.5 Waylis Therapeutics Recent Developments
  61. 8.11 Zydus
  62. 8.11.1 Zydus Company Information
  63. 8.11.2 Zydus Business Overview
  64. 8.11.3 Zydus Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zydus Dutasteride Drug Product Portfolio
  66. 8.11.5 Zydus Recent Developments
  67. 8.12 Chengdu Suncadia Medicine
  68. 8.12.1 Chengdu Suncadia Medicine Company Information
  69. 8.12.2 Chengdu Suncadia Medicine Business Overview
  70. 8.12.3 Chengdu Suncadia Medicine Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio
  72. 8.12.5 Chengdu Suncadia Medicine Recent Developments
  73. 8.13 Jiangsu Wangao Pharmaceutical
  74. 8.13.1 Jiangsu Wangao Pharmaceutical Company Information
  75. 8.13.2 Jiangsu Wangao Pharmaceutical Business Overview
  76. 8.13.3 Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio
  78. 8.13.5 Jiangsu Wangao Pharmaceutical Recent Developments
  79. 8.14 Qilu Pharmaceutical
  80. 8.14.1 Qilu Pharmaceutical Company Information
  81. 8.14.2 Qilu Pharmaceutical Business Overview
  82. 8.14.3 Qilu Pharmaceutical Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Qilu Pharmaceutical Dutasteride Drug Product Portfolio
  84. 8.14.5 Qilu Pharmaceutical Recent Developments
  85. 8.15 Humanwell Puracap
  86. 8.15.1 Humanwell Puracap Company Information
  87. 8.15.2 Humanwell Puracap Business Overview
  88. 8.15.3 Humanwell Puracap Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Humanwell Puracap Dutasteride Drug Product Portfolio
  90. 8.15.5 Humanwell Puracap Recent Developments
  91. 8.16 Sichuan Gowell Pharmaceutical
  92. 8.16.1 Sichuan Gowell Pharmaceutical Company Information
  93. 8.16.2 Sichuan Gowell Pharmaceutical Business Overview
  94. 8.16.3 Sichuan Gowell Pharmaceutical Dutasteride Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio
  96. 8.16.5 Sichuan Gowell Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dutasteride Drug Value Chain Analysis
  2. 9.1.1 Dutasteride Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dutasteride Drug Production Mode & Process
  6. 9.2 Dutasteride Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dutasteride Drug Distributors
  9. 9.2.3 Dutasteride Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst